Sun Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 12-12-2024
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.15 Cr
as on 12-12-2024
- Revenue 5.23%
(FY 2020)
- Profit 149.23%
(FY 2020)
- Ebitda 180.92%
(FY 2020)
- Net Worth 24.31%
(FY 2020)
- Total Assets 27.37%
(FY 2020)
About Sun Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹4.15 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rameshkumar Porwal, Deepan Porwal, and Naman Porwal serve as directors at the Company.
- CIN/LLPIN
U24231KA2002PTC030804
- Company No.
030804
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sun Life Sciences Private Limited offer?
Sun Life Sciences Private Limited offers a wide range of products and services, including Antiseptic Gel, Lotion & Cream, Povidone Iodine Ointment, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Sun Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepan Porwal  | Whole-Time Director | 18-Feb-2013 | Current |
| Rameshkumar Porwal | Whole-Time Director | 01-Jun-2004 | Current |
| Naman Porwal | Whole-Time Director | 01-Oct-2020 | Current |
Financial Performance of Sun Life Sciences.
Sun Life Sciences Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.23% increase. The company also saw a substantial improvement in profitability, with a 149.23% increase in profit. The company's net worth Soared by an impressive increase of 24.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sun Life Sciences?
In 2022, Sun Life Sciences had a promoter holding of 55.00% and a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Dec 2014 | ₹3.00 Cr | Satisfied |
Ing Vysya Bank Limited Creation Date: 30 Nov 2010 | ₹7.50 M | Satisfied |
Unon Bank Of India Creation Date: 23 Jul 2004 | ₹4.00 M | Satisfied |
How Many Employees Work at Sun Life Sciences?
Sun Life Sciences has a workforce of 26 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
